Freeport-McMoRan (FCX)

NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) --

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

NEW YORK - November 21, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Freeport-McMoRan Inc. (NYSE: FCX) of a class action securities lawsuit.

Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”).

LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Freeport-McMoRan Inc. (“Freeport” or “the Company”) (NYSE: FCX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Telix Pharmaceuticals Limited (NASDAQ:TLX), Freeport-McMoran Inc. (NYSE:FCX), and Primo Brands Corporation (NYSE:PRMB). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Law Offices of Howard G. Smith reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”).

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Freeport-McMoran To Contact Him Directly To Discuss Their Options

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

NEW YORK - November 20, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Freeport-McMoRan Inc. (NYSE: FCX) of a class action securities lawsuit.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”). Freeport investors have until January 12, 2026 to file a lead plaintiff motion.

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) between February 15, 2022 and September 24, 2025, inclusive.

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”). Freeport investors have until January 12, 2026 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”). Freeport investors have until January 12, 2026 to file a lead plaintiff motion.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Freeport-McMoRan Inc. (“Freeport” or “the Company”) (NYSE: FCX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Freeport-McMoRan Inc. (NYSE: FCX) publicly traded securities between February 15, 2022 and September 24, 2025, both dates inclusive (the “Class Period”), have until January 12, 2026 to seek appointment as lead plaintiff of the Freeport-McMoRan class action lawsuit. Captioned Reed v. Freeport-McMoRan Inc., No. 25-cv-04243 (D. Ariz.), the Freeport-McMoRan class action lawsuit charges Freeport-McMoRan and certain of Freeport-McMoRan’s top current and former executives with violations of the Securities Exchange Act of 1934.

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws.

Freeport (NYSE: FCX) announced today plans to restore large-scale production from PT Freeport Indonesia’s (PTFI) Grasberg operations in Central Papua, Indonesia.

SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Cytokinetics, Incorporated (NASDAQ:CYTK), Quanex Building Products Corporation (NYSE:NX), Freeport-McMoran Inc. (NYSE:FCX), and Primo Brands Corporation (NYSE:PRMB). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Freeport-McMoRan Inc. (“Freeport” or “the Company”) (NYSE: FCX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) and reminds investors of the January 12, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Freeport-McMoRan Inc. (“Freeport” or the “Company”) (NYSE: FCX) investors concerning the Company’s possible violations of the federal securities laws.